American University of Beirut

​​​​​​

• Commentary on the Endocrine Society Clinical Practice Guideline on the Treatment of Hypercalcemia of Malignancy in Adults.
  El-Hajj Fuleihan G*, Drake MT.  Metabolism 2023 Jun;143:155553.doi: 10.1016/j.metabol.2023.155553.
  
• ​​​​​​​​​Metabolism, Clinical and Experimental: Seventy Years Young and Growing.​
  Polyzos​ S, Hill M, El-Hajj Fuleihan G, Gnudi L, Kim YB, Larsson S, Masuzaki H, Matarese G, Sanoudou D, Tena Sempere M, Mantzoros C. Metabolism 2022; 137:155333.
  
• Reply to vitamin D deficiency in covid-19: mixing up cause and consequence. ​
  Chakhtoura M, El Hajj Fuleihan G. Metabolism 2021​; 115:154462.
• Myths and facts on vitamin D amidst the covid-19 pandemic.​​
  Chakhtoura M, Napoli N, El Hajj Fuleihan G. Metabolism Clinical and Experimental  2020; 109:154276.
• Building bridges to address the osteoporosis crisis.
  El-Hajj Fuleihan G. J Clin Endocrinol Metab 2020 ;105(4):1292-1293.
• Can the sunshine vitamin melt the fat?​​​​​
  El-Hajj Fuleihan G. Metabolism 2012; 61:603-610.
• Hypovitaminosis D in Developing Countries—Prevalence, Risk Factors and Outcomes.
  Arabi A, El Rassi R and El-Hajj Fuleihan G. Nat Rev Endocrinol 2010; 6:550-561.
• How effective is risedronate in preventing bone loss in patients on high dose steroids? practice point commentary.
  Asma A, El-Hajj Fuleihan G. Nature Clinical Practice Endocrinology 2008; 4(10):540-541.
• Hyperparathyroidism: time to reconsider current clinical decision paradigms?​
  El-Hajj Fuleihan G. Editorial. J Clin Endocrinol Metab 2008; 93(9):3302-3304.
• Tibolone and the promise of ideal hormone replacement therapy.
  El-Hajj Fuleihan G. editorial. New Engl J Med 2008; 359(7):753-755.​
  
• Strontium ranelate: a novel therapy for osteoporosis or a permutation of the same?
  El-Hajj Fuleihan G. editorial. N Engl J Med 2004; 350:504-506.
• Tissue-specific estrogens—the promise for the future.​​
  ​El-Hajj Fuleihan G. editorial. N Engl J Med 1997; 337:1686-1687.​​